Skip to main content
. 2018 Mar 12;118(7):966–971. doi: 10.1038/s41416-018-0021-1

Fig. 2.

Fig. 2

Survival outcomes in patients with advanced biliary tract cancer who received everolimus. Kaplan–Meier estimates of progression-free survival (a) and overall survival (b). CI confidence interval